Literature DB >> 23383653

Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update.

M C Kew1.   

Abstract

Chronic hepatitis B and C virus infections are universally accepted as causes of hepatocellular carcinoma in humans. Hepatitis A and E viruses cause only acute self-limiting infections of the liver. Of the remaining hepatitis viruses - Delta hepatitis, hepatitis G (GB-C), TT and SEN - all have at some time been incriminated as causes of hepatocellular carcinoma. Delta hepatitis virus requires helper functions from hepatitis B virus to become invasive. Chronic Delta/hepatitis B viral co-infection runs a more severe course than that resulting from chronic hepatitis B virus infection alone, with progression to cirrhosis being more likely and more rapid. A substantial majority of the early studies did not find an increased incidence of hepatocellular carcinoma in co-infected individuals. But more recently, an increased incidence of the tumour has been recorded more often than no increase. Further studies are needed to draw a firm conclusion with regard to the hepatocarcinogenic effect of dual Delta/hepatitis B virus co-infection. With one exception, no published study (of 13) has incriminated chronic infection with hepatitis G virus as a cause of hepatocellular carcinoma. The dissenting study, published in 1999, was the only one performed in the United States. Fewer studies of the hepatocarcinogenic effect of TT virus have been performed. Apart from one study, published in 1999, no convincing evidence is available that supports a causal role for TT virus in hepatocarcinogenesis. The exception was in Japanese patients with high hepatitis C viral loads but independent of chronic hepatitis C virus infection. No evidence has been produced to indicate that SEN virus causes hepatocellular carcinoma.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23383653     DOI: 10.1111/jvh.12043

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  9 in total

1.  Viral metagenomics applied to blood donors and recipients at high risk for blood-borne infections.

Authors:  Virginie Sauvage; Syria Laperche; Justine Cheval; Erika Muth; Myriam Dubois; Laure Boizeau; Charles Hébert; François Lionnet; Jean-Jacques Lefrère; Marc Eloit
Journal:  Blood Transfus       Date:  2016-03-16       Impact factor: 3.443

2.  Associations between MTHFR Ala222Val polymorphism and risks of hepatitis and hepatitis-related liver cancer: a meta-analysis.

Authors:  Ruiying Zheng; Wenyuan Zhao; Dongwei Dai; Chengzhong Li
Journal:  Tumour Biol       Date:  2013-10-24

Review 3.  Emerging challenges in managing hepatitis B in HIV patients.

Authors:  Vincent Soriano; Pablo Labarga; Carmen de Mendoza; José M Peña; José V Fernández-Montero; Laura Benítez; Isabella Esposito; Pablo Barreiro
Journal:  Curr HIV/AIDS Rep       Date:  2015-09       Impact factor: 5.071

Review 4.  Hepatocarcinogenesis associated with hepatitis B, delta and C viruses.

Authors:  Elham Shirvani-Dastgerdi; Robert E Schwartz; Alexander Ploss
Journal:  Curr Opin Virol       Date:  2016-08-06       Impact factor: 7.090

Review 5.  Epidemiology of acute and chronic hepatitis B and delta over the last 5 decades in Italy.

Authors:  Evangelista Sagnelli; Caterina Sagnelli; Mariantonietta Pisaturo; Margherita Macera; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

6.  The Prevalence and Risk Factors of Hepatitis Delta Virus in HIV/HBV Co-Infected Patients in Shiraz, Iran, 2012.

Authors:  Mohammad Motamedifar; Mohammad Taheri; Kamran Bagheri Lankarani; Mina Gholami; Mahmood Amini Lari; Hossein Faramarzi; Jamal Sarvari
Journal:  Iran J Med Sci       Date:  2015-09

7.  Pro-Inflammatory Cytokine IL-1β Up-Regulates CXC Chemokine Receptor 4 via Notch and ERK Signaling Pathways in Tongue Squamous Cell Carcinoma.

Authors:  Yi Sun; Demao Zhu; Guihua Wang; Di Wang; Huashan Zhou; Xueting Liu; Manli Jiang; Lingjuan Liao; Zhiguang Zhou; Jinyue Hu
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Cancer risk among 21st century blood transfusion recipients.

Authors:  T O Yang; B J Cairns; G K Reeves; J Green; V Beral
Journal:  Ann Oncol       Date:  2017-02-01       Impact factor: 32.976

Review 9.  Hepatitis delta: epidemiology, diagnosis and management 36 years after discovery.

Authors:  Mazen Noureddin; Robert Gish
Journal:  Curr Gastroenterol Rep       Date:  2014-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.